Salvia miltiorrhiza (Danshen) injection ameliorates iron overload-induced cardiac damage in mice

Planta Medica

Volumn 79, Issue 9, 2013, Pages 744-752

  Zhang, Jian Ping ^a   Zhang, Yuan Yuan ^a   Zhang, Ying ^a   Gao, Yong Gang ^a   Ma, Juan Juan ^a   Wang, Na ^a   Wang, Jiang Yan ^b   Xie, Yun ^a   Zhang, Feng Hua ^a   Chu, Li ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Bethune Military Medical College   (China)

Author keywords

antioxidation; cardioprotection; HPLC UV; Lamiaceae; Salvia miltiorrhiza

Indexed keywords

3 (3,4 DIHYDROXYPHENYL)LACTIC ACID; CREATINE KINASE; CREATINE KINASE ISOENZYME; CREATINE KINASE MB; DEFEROXAMINE; EOSIN; GLUTATHIONE PEROXIDASE; HEMATOXYLIN; IRON DEXTRAN; LACTATE DEHYDROGENASE; PROTOCATECHUALDEHYDE; SALVIA MILTIORRHIZA EXTRACT; SALVIANOLIC ACID B; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG MEGADOSE; ENZYME ACTIVITY; HEART INJURY; HEART PROTECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IRON CHELATION; IRON OVERLOAD; LIPID OXIDATION; LIPID PEROXIDATION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; RADIATION DETECTION; STAINING; ULTRAVIOLET RADIATION;

ANIMALS; BENZALDEHYDES; BENZOFURANS; CATECHOLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATINE KINASE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; GLUTATHIONE PEROXIDASE; HEART; INJECTIONS, INTRAPERITONEAL; IRON OVERLOAD; L-LACTATE DEHYDROGENASE; LACTATES; MALE; MEDICINE, CHINESE TRADITIONAL; MICE; MYOCARDIUM; PHENANTHROLINES; SALVIA MILTIORRHIZA; SUPEROXIDE DISMUTASE;

LAMIACEAE; MUS; SALVIA MILTIORRHIZA;

EID: 84879218245     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0032-1328588     Document Type: Article

References (44)

1. Andrews N. C. Disorders of iron metabolism. N Engl J Med: 1999; 341 1986 1995
2. Hentze M. W., Muckenthaler M. U., Andrews N. C. Balancing acts: molecular control of mammalian iron metabolism. Cell: 2004; 117 285 297
3. Napier I., Ponka P., Richardson D. R. Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood: 2005; 105 1867 1874
4. Omara F. O., Blakley B. R. Influence of low dietary iron and iron overload on urethan-induced lung tumors in mice. Can J Vet Res: 1993; 57 209 211
5. Herbert V. Iron worsens high-cholesterol-related coronary artery disease. Am J Clin Nutr: 1994; 60 299 300
6. McCord J. M. Effects of positive iron status at a cellular level. Nutr Rev: 1996; 54 85 88
7. 2+ channels in iron transport and iron-overload cardiomyopathy. J Mol Med (Berl): 2006; 84 349 364
8. Steensma D. P., Hoyer J. D., Fairbanks V. F. Hereditary red blood cell disorders in middle eastern patients. Mayo Clin Proc: 2001; 76 285 293
9. Niederau C., Fischer R., Purschel A., Stremmel W., Haussinger D., Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology: 1996; 110 1107 1119
10. Cecchetti G., Binda A., Piperno A., Nador F., Fargion S., Fiorelli G. Cardiac alterations in 36 consecutive patients with idiopathic haemochromatosis: polygraphic and echocardiographic evaluation. Eur Heart J: 1991; 12 224 230
11. Palka P., Macdonald G., Lange A., Burstow D. J. The role of Doppler left ventricular filling indexes and Doppler tissue echocardiography in the assessment of cardiac involvement in hereditary hemochromatosis. J Am Soc Echocardiogr: 2002; 15 884 890
12. Olivieri N. F., Brittenham G. M. Iron-chelating therapy and the treatment of thalassemia. Blood: 1997; 89 739 761
13. Niederau C., Fischer R., Sonnenberg A. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med: 1985; 313 1256 1262
14. Olivieri N. F. The beta-thalassemias. N Engl J Med: 1999; 341 99 109
15. Modell B., Khan M., Darlison M. Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet: 2000; 355 2051 2052
16. Galanello R. Iron chelation: new therapies. Semin Hematol: 2001; 38 73 76
17. Chaston T. B., Richardson D. R. Iron chelators for the treatment of iron overload disease: relationship between structure, redox activity, and toxicity. Am J Hematol: 2003; 73 200 210
18. Wang G., Wang L., Xiong Z. Y., Mao B., Li T. Q. Compound salvia pellet, a traditional Chinese medicine, for the treatment of chronic stable angina pectoris compared with nitrates: a meta-analysis. Med Sci Monit: 2006; 12 SR1 SR7
19. Zhao G. R., Zhang H. M., Ye T. X., Xiang Z. J., Yuan Y. J., Guo Z. X., Zhao L. B. Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food Chem Toxicol: 2008; 46 73 81
20. Yokozawa T., Dong E., Oura H., Kashiwagi H., Nonaka G., Nishioka I. Magnesium lithospermate B suppresses the increase of active oxygen in rats after subtotal nephrectomy. Nephron: 1997; 75 88 93
21. Moon C. Y., Ku C. R., Cho Y. H., Lee E. J. Protocatechuic aldehyde inhibits migration and proliferation of vascular smooth muscle cells and intravascular thrombosis. Biochem Biophys Res Commun: 2012; 423 116 121
22. Gambling L., Charania Z., Hannah L., Antipatis C., Lea R. G., Mcardle H. J. Effect of iron deficiency on placental cytokine expression and fetal growth in the pregnant rat. Biol Reprod: 2002; 66 516 523
23. Link G., Konijn A. M., Hershko C. Cardioprotective effect of alpha-tocopherol, ascorbate, deferoxamine, and deferiprone: mitochondrial function in cultured, iron-loaded heart cells. J Lab Clin Med: 1999; 133 179 188
24. Livrea M. A., Tesoriere L., Pintaudi A. M., Calabrese A., Maggio A., Freisleben H. J., DArpa D., DAnna R., Bongiorno A. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood: 1996; 88 3608 3614
25. Cheng T. O. Cardiovascular effects of Danshen. Int J Cardiol: 2007; 121 9 22
26. Cheng T. O. Danshen: a versatile Chinese herbal drug for the treatment of coronary heart disease. Int J Cardiol: 2006; 113 437 438
27. Zhou L., Zuo Z., Chow M. S. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol: 2005; 45 1345 1359
28. Wang M., Liu J., Zhou B., Xu R., Tao L., Ji M., Zhu L. Acute and sub-chronic toxicity studies of Danshen injection in Sprague-Dawley rats. J Ethnopharmacol: 2012; 141 96 103
29. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB J: 2008; 22 659 661
30. Han J. Y., Fan J. Y., Horie Y., Miura S., Cui D. H., Ishii H., Hibi T., Tsuneki H., Kimura I. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol Ther: 2008; 117 280 295
31. Zhou R., He L. F., Li Y. J., Shen Y., Chao R. B., Du J. R. Cardioprotective effect of water and ethanol extract of Salvia miltiorrhiza in an experimental model of myocardial infarction. J Ethnopharmacol: 2012; 139 440 446
32. Link G., Tirosh R., Pinson A., Hershko C. Role of iron in the potentiation of anthracycline cardiotoxicity: identification of heart cell mitochondria as a major site of iron-anthracycline interaction. J Lab Clin Med: 1996; 127 272 278
33. Vanella A., Campisi A., di Giacomo C., Sorrenti V., Vanella G., Acqaviva R. Enhanced resistance of adriamycin-treated MCR-5 lung fibroblasts by increased intracellular glutathione peroxidase and extracellular antioxidants. Biochem Mol Med: 1997; 62 36 41
34. Saad S. Y., Najjar T. A., Al-Rikabi A. C. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res: 2001; 43 211 218
35. Olivieri N. F., Brittenham G. M., McLaren C. E., Templeton D. M., Cameron R. G., Fleming K. A. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N Engl J Med: 1998; 339 417 423
36. 2+ channel modifiers: possible implications in iron overload. Circ Res: 1999; 84 1302 1309
37. Benzie I. F. Lipid peroxidation: a review of causes, consequences, measurement and dietary influences. Int J Food Sci Nutr: 1996; 47 233 261
38. Dawson E. A., Shave R., George K., Whyte G., Ball D., Gaze D., Collinson P. Cardiac drift during prolonged exercise with echocardiographic evidence of reduced diastolic function of the heart. Eur J Appl Physiol: 2005; 94 305 309
39. Chow S. N., Wu C. C., Huang S. C., Tsai Y. L., Chien C. H. Combined analysis of serum lactic dehydrogenase levels and isozyme patterns in ovarian neoplasms. Proc Natl Sci Counc Repub China B: 1991; 15 101 104
40. de Zwart L. L., Meerman J. H., Commandeur J. N., Vermeulen N. P. Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med: 1999; 26 202 226
41. Gutteridge J. M. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem: 1995; 41 1819 1828
42. Fridovich I. Oxygen radicals from acetaldehyde. Free Radic Biol Med: 1989; 7 557 558
43. Forman H. J., Dickinson D. A. Introduction to serial reviews on 4-hydroxy-2-nonenal as a signaling molecule. Free Radic Biol Med: 2004; 37 594 596
44. Huang W. M., Yan H., Jin J. M., Yu C., Zhang H. Beneficial effects of berberine on hemodynamics during acute ischemic left ventricular failure in dogs. Chin Med J (Engl): 1992; 105 1014 1019